Foxp3
+ cells may be "inflammatory" Treg cells in the pathological microenvironments. These cells may contribute to the pathogenesis of ulcerative colitis through inducing inflammatory cytokines and inhibiting local T cell immunity, and in turn may mechanistically link human chronic inflammation to tumor development. Our data therefore challenge commonly held beliefs of the anti-inflammatory role of Treg cells and suggest a more complex Treg cell biology, at least in the context of human chronic inflammation and associated carcinoma. The Journal of Immunology, 2011, 186: 000-000.
T he relationship between chronic inflammation and cancer has been noted for centuries. It is estimated that at least 15-20% of cancers are associated with inflammation (1, 2) . A typical example of this relationship is chronic ulcerative colitis and the associated colon cancer in humans. In the United States, colitis affects 4-6 of 100,000 people. In this population, the risk of colon cancer is 5-fold above the incidence of sporadic colon cancer, reaching upwards of 18% after 30 y disease (3, 4) . Despite the clinical relationship between ulcerative colitis and colon cancer, the molecular and cellular links between infiltrating immune cells, inflammation, and cancer development are poorly understood in humans.
In the current study we focused on patients with chronic ulcerative colitis and colon carcinoma. We have investigated the phenotype, cytokine profile, generation, and functions of CD4 + T cell subsets in the microenvironment of chronic ulcerative colitis. To our knowledge, our results provide the first evidence showing that colitic IL-17 +
+ cells are functionally "inflammatory" regulatory T cells in the chronic inflammatory microenvironments. These cells may play unique roles in the pathogenesis of chronic inflammation and the development of inflammationassociated cancer in patients.
Materials and Methods

Human subjects and human tissues
We studied chronic ulcerative colitis patients, patients with colitic-associated colon carcinoma, melanoma, ovarian cancer, and renal cell carcinoma. Ulcerative colitic tissues were from patients with ulcerative colitis presenting for prophylactic colectomy or/and diagnostic biopsy sampling. The diagnosis of ulcerative colitis was determined according to established guidelines based on endoscopic, histopathological, and radiological criteria. Patients who had received no treatment with immunosuppressive agents were recruited for this study. Tissue sampling for inflamed lesions and adjacent tissues was directed toward the same colonic or ileal segment, if possible. There usually is not any "absolutely normal" tissue in ulcerative colitis or colitis-associated colon carcinoma. We took grossly "normal" tissue from at least 5 cm away from active colitic and cancer locations. These normal tissues were ideal inflammatory controls for colitic tissues. Crohn's disease was not included in the study. Psoriatic skin biopsies were obtained from patients with psoriasis, as we previously reported (5). Patients gave written, informed consent. Cells and tissues were obtained from blood and human tissues as we described (6) . The study was approved by the local Institutional Review Boards.
intracellularly with anti-IL-2, anti-TNF-a, anti-IFN-g (BD Biosciences), and anti-FOXP3 (eBioscience). Samples were acquired on a LSR II (BD Biosciences) and data were analyzed with Diva software (BD Biosciences). bright T cells. The number of regulatory T (Treg) cells added in the immune suppression assay was based on the quantification of Foxp3 (not CD25) in the sorted viable CD4 + CD25 bright T cells (7) . In some cases T cell clones were used. The responder T cells and the APCs, macrophages, were enriched from peripheral blood. The immune suppression assay was performed as we described (8) . Briefly, different numbers of tested cells (CD4 +   Foxp3 + T cells or T cell clones) were added into the coculture system containing the same responder T cells and APCs for 3 d. T cell proliferation was determined by thymidine incorporation. T cell cytokines were detected in the supernatants with ELISA kit (R&D Systems).
Immune suppression assay
Quantitative real-time PCR
Total RNA was isolated with Qiagen reagent. The RNA was reverse transcribed into cDNA using oligo(dT) primers and SuperScript II reverse transcriptase (Invitrogen), according to the manufacturer's instructions. The primer sequence combinations spanned contact sequences of subsequent exons. For amplification, the SyberGreen qPCR mix was used (Invitrogen). Each reaction was run in triplicate on the Mastercycler machine (Eppendorf) and was normalized to housekeeping gene GAPDH transcripts.
T cells clones
Peripheral CD4
+ T cells were isolated from two independent donors with negative enrichment method through magnetic bead selection (RosetteSep; StemCell Technologies, Vancouver, BC, Canada). T cells were expanded and cloned with 2.5 mg/ml anti-CD3 and 1.25 mg/ml anti-CD28 mAb (BD Biosciences) and 5 ng/ml rhIL-2 (R&D System) in the presence of irradiated allogeneic PBMCs as feeders as previously described (9) . The clones were tested for Foxp3 and IL-17 expression by FACS and used for functional experiments.
Inflammatory cytokines in the colitic environments
Single-cell suspensions were made from fresh ulcerative colitis tissues. Colitic CD4 +
CD25
bright T cells (10 6 /ml) were sorted to high purity and activated with anti-CD3 and anti-CD28 beads for 48 h. The supernatants were collected and then cultured with autologous ulcerative colitic colon epithelial cells (2 3 10 6 /ml) for 24 h with or without anti-human IL-17 receptor. Colon epithelial cells were defined by FACS as lineage 2 EpCam + nonimmune cells. The production of cytokines was analyzed by ELISA kits (R&D Systems).
Statistical analysis
The Wilcoxon signed-rank test was used to determine pairwise differences, and the Mann-Whitney U test was used to determine differences between groups (10). A p value , 0.05 was considered as significant. All statistical analysis was done on Statistica software (StatSoft, Tulsa, OK) and is further described in the figure legends.
Results
IL-17 + Foxp3
+ cells in ulcerative colitis and colitis-associated colon carcinoma T cell activation and infiltration has been thought to play a major contribution to the pathogenesis of ulcerative colitis (11) . However, the detailed phenotype of T cell subsets and their roles in human ulcerative colitis are poorly understood. A minor population of IL-17 + Foxp3 + cells was detected in the peripheral blood in healthy humans (12, 13 (8, 14) , moderate levels of blood Treg cells (Fig. 1A) and high levels of tissue Treg cells were detected in the colonic mucosa from patients with ulcerative colitis (Fig. 1B) and colitis-associated colon carcinoma (Fig. 1C) , as well as in the tissues of ovarian cancer, renal cell carcinoma, and melanoma (Fig. 1D) . Although the levels of Th17 cells were generally lower than Treg cells, we detected higher levels of Th17 cells in the mucosa of colitis and of colon carcinoma (Fig. 1B, 1C ) and moderate levels of Th17 cells in other types of tumor we examined (Fig. 1D) . Interestingly, a significant population of IL-17 + Foxp3 + T cells was observed exclusively in the mucosa of colitic colon tissues and colitic-associated colon carcinoma, not in the adjacent tissues (Fig. 1B, 1C, 1E ). The levels of IL-17 + Foxp3 + T cells were minimal (,0.3%) in other types of cancer, including ovarian cancer, melanoma, and renal cell carcinoma (Fig. 1D, 1E ), as well as in normal peripheral blood (,0.3%) ( Results are expressed as the mean values of IL-17A gene expression 6 SD from three independent experiments (blood, n = 10; ulcerative colitis, n = 8; ulcerative colitis-associated colon cancer, n = 9; ovarian cancer tissues, n = 17; melanoma tissues, n = 12; renal cell carcinoma, n = 9). *p , 0.01 compared with other groups as determined by Mann-Whitney U test. (Fig. 3A) . Furthermore, multiple combinations of the Th17-cytokine mixture failed to stimulate the development of IL-17 + Foxp3 + cells in the absence of APCs (Fig. 3B) . The data indicate that APCs are essential for the development of IL-17 + Foxp3 + cells. We further (Fig. 4A-D) were sorted into naive versus memory CD4 + T cells as we described (see Materials and Methods). We showed that in the presence of optimal IL-17 + Foxp3 + cell polarization conditions (Fig. 3C) , IL-17 + Foxp3 + cells were induced from memory but not naive T cells (*p , 0.01) (Fig. 4A, 4B ).
cells, and used cells with high levels of Foxp3 expression for further experiments (see Materials and Methods
Th17 cells are enriched in CCR6 + T cells (5, (15) (16) (17) (Fig. 4F, 4G ). However, memory Treg cells were more efficiently induced into IL-17 +
Foxp3
+ cells (*p , 0.01) (Fig. 4F, 4G (Fig. 4H) . The induced IL-17 + Foxp3
+ cells produced high levels of IL-17 (*p , 0.01) (Fig. 4I) . high T cells to high purity and determined the expression of Foxp3 and IL-17 in the sorted CD4 + CD25 high T cells (Fig. 5A) . The suppressive assay was assessed utilizing CD4 + Foxp3 + T cells and responder T cells from the same donors. We observed similar suppressions on T cell proliferation (Fig. 5B) and IFN-g production (Fig. 5C ) by Foxp3 + CD4 + T cells from blood, tumors, and colitic tissues. The suppression was dose-dependent (Fig. 5B) (Fig. 6A, 6B ). Blood Treg cells expressed minimal IL-17 (Fig. 1A) . Blood Treg cells failed to induce inflammatory cytokines (not shown). The levels of IL-1b and IL-6 were increased in the presence of coltic Treg cell supernatants (Fig. 6A, 6B ). Blockade of IL-17 receptor reduced the production of IL-1b and IL-6 stimulated by colitic Treg cells (Fig. 6A, 6B ). Consistent with this observation, we showed that colitic Treg cells expressed high levels of IL-17 (Fig. 1A) . Furthermore, higher levels of IL-17 were detected in ulcerative colitis tissues, as compared with "normal" colon tissues (Fig. 1C) . We detected low levels of IL-17 in the sera in patients with ulcerative colitis, which were slightly higher than that in the sera of healthy donors (not shown). The data indicate that Th17 and IL-17 + Foxp3 + T cells may play an active role in the local environment.
Discussion
In the current study, we have investigated the nature of IL-17 +
Foxp3
+ T cells in patients with ulcerative colitis. + Treg cells play a significant role in suppressing tumor-associated Ag-specific immunity, tempering inflammation, and controlling the pathogenesis of autoimmune diseases (14, (21) (22) (23) (24) . Foxp3 in combination with cytokine profiles are useful markers to phenotypically define primary human Treg cells in tumor and inflammatory tissues (7, 25, 26) . In contrast, Th17 cells represent a different inflammatory component and play an active role in inflammation (27) (28) (29) (30) (31) (32) (33) (34) (35) and cancer (36) . Interestingly, recent studies suggest considerable levels of plasticity between different T cell lineages, and they point toward potent peripheral regulation of effector T cell subset development in the specific microenvironment (37, 38) . For instance, peripheral mature Treg cells can be converted into Th17 cells, an event favored by inflammation in the context of IL-6 production (13, (38) (39) (40) . In support of this possibility, a minor population of IL-17 + Foxp3 + cells can be observed in the tonsils (13) and peripheral blood (12, 13, 41, 42) in humans, as well as in the small intestine in mice (43) . However, it is unknown whether IL-17 + Foxp3 + cells can be detected in the pathological setting, and, if so, what is their phenotype, cytokine profile, generation requirements, and functional relevance in humans?
To our knowledge, we have observed for the first time that substantial numbers of IL-17 + regulatory T cells selectively accumulate in the mucosa of ulcerative colitis and colon cancer carcinoma. This population is barely visible in the peripheral blood and in multiple human tumors, including ovarian cancer, breast cancer, melanoma, and renal cell carcinoma. The distribution suggests that this T cell population may play a role in the chronic inflammatory environment of mucosa and colon.
We + T cells may be a "special" effector T cell population expressing multiple effector cytokines. These cytokines may directly and indirectly enhance inflammation in the colitic environment. Second, we have sorted these cells with high purity and tested their effects on the signature inflammatory gene expression described in ulcerative colitis. To our surprise, we have found that Treg cells induce, rather than suppress, the production of IL-1 and IL-6 by colitic cells. Blocking IL-17 receptor signaling results in a significant inhibition of IL-1 and IL-6 production in colitic cells. The data indicate that functional IL-17 is derived from Foxp3 + IL-17 + CD4 + T cells as an importation portion of the Treg cell population. In line with this possibility, elevated inflammatory cytokines are detected in the fresh colitic environment. It has been reported that recombinant IL-17 induces IL-6 expression in other systems (50) (51) (52) (53) . As IL-1 and IL-6 play crucial roles in ulcerative colitis (11, (54) (55) (56) (57) , it is likely that IL-17-expressing T cells, including Th17 cells and Foxp3 + IL-17 + CD4 + T cells, promote the production of inflammatory cytokines and potentially contribute to early tumorigenesis associated with immunopathogenesis of ulcerative colitis in patients.
In support of this possibility, recent mouse studies demonstrate that CD4 + T cells may promote mammary epithelial cell malignancy (58) . Notably, although the link between inflammation and cancer has been noted for .100 y, only recently have investigators started to address the cellular, molecular, and genetic causal relationships between inflammation and cancer. Compelling evidence has demonstrated that inflammation orchestrates the microenvironment around tumors, contributing to the proliferation, migration, and survival of cancer cells that can result in tumor invasion, migration, and metastasis (1, 2) . On the other hand, inflammatory reactions in the tumor microenvironment are an important component of the tumor-associated immune response.
Inflammatory (immune) cells and molecules may have crucial roles in initiating and maintaining protective anti-tumor immunity (22, 36) . As we have demonstrated in patients with chronic colitis in the current study, the specific nature of the inflammatory (immune) response and the tissue context may determine the beneficial versus the detrimental impact of inflammation on tumor pathology. Therefore, in addition to colitis-associated colon cancer, our study may be important for understanding the pathogenesis of other inflammation-associated human cancers, including hepatitis-associated hepatocellular carcinoma, atrophy gastritisassociated gastric cancer, and pancreatitis-associated pancreatic carcinoma.
In summary, human IL-17 + Foxp3 + cells induce proinflammatory cytokines and suppress T cell function, exhibiting the dual inflammatory and regulatory function. These inflammatory regulatory T cells are induced from memory CCR6 + T cells and Treg cells, and they may contribute to promoting active inflammation and tumor development through multiple modes of action in the local environment.
